Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Organ Dysfunction and Mortality by Monitoring the Administration of Opioids and Hypnotics in Patients at High Postoperative Risk: the Opti-Two Study. A Multi-center Controlled Randomized Study.

NCT05893030 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.

NCT NCT05893030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Organ Dysfunction and Mortality by Monitoring the Administration of Opioids and Hypnotics in Patients at High Postoperative Risk: the Opti-Two Study. A Multi-center Controlled Randomized Study.
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Phase
Not applicable
Overall status
Recruiting
Start date
October 12, 2023
Completion date
February 29, 2028
Enrollment
1,132 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

sedation and analgesia monitoring